Jason Imbriglio, PhD
About Jason Imbriglio, PhD
Jason Imbriglio, Vice President of Discovery Chemistry
Jason Imbriglio, PhD, currently serves as the Vice President of Discovery Chemistry. With more than 16 years of experience in drug discovery and medicinal chemistry, he has played a significant role in advancing scientific research and development in the field.
Jason Imbriglio's Career and Leadership at Merck
Jason Imbriglio was a recognized leader in Merck’s global discovery chemistry department. Throughout his tenure at Merck, he held positions of increasing responsibility, culminating in his role as Director of Chemical Biology. He was a founding member of Merck’s chemical biology group and co-led the targeted protein degradation group. His contributions include the discovery of five development candidates and three Investigational New Drug (IND) filings.
Notable Contributions and Patents by Jason Imbriglio
Jason Imbriglio is a co-inventor in the discovery of the beta-lactamase inhibitor Relebactam. Over his career, he has authored more than 30 peer-reviewed journal articles and holds 12 patents across a diverse set of therapeutic areas. His extensive research and innovations have made significant impacts on drug discovery and development.
Jason Imbriglio's Educational Background
Jason Imbriglio holds a Bachelor of Arts degree in Biology and a Bachelor of Science degree in Chemistry from the University of Massachusetts in Amherst. He was also a Howard Hughes Undergraduate Research Fellow. He earned his Doctor of Philosophy degree in Organic Chemistry from the University of Arizona in Tucson and completed a National Institute of Health Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship at Boston College.